IRONWOOD PHARMACEUTICALS, INC. Deferred Tax Assets, Deferred Income
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Deferred Tax Assets, Deferred Income of $3.36 million as of 2015-12-31, per its 10-K filed 2017-02-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2017-02-22
- 2015-12-31: Deferred Tax Assets, Deferred Income $3.36M.
- 2014-12-31: Deferred Tax Assets, Deferred Income $4.22M.
- 2013-12-31: Deferred Tax Assets, Deferred Income $6.43M.
- 2012-12-31: Deferred Tax Assets, Deferred Income $8.30M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2015-12-31 | $3.36M 10-K · filed 2017-02-22 |
| 2014-12-31 | $4.22M 10-K · filed 2016-02-19 |
| 2013-12-31 | $6.43M 10-K · filed 2015-02-18 |
| 2012-12-31 | $8.30M 10-K · filed 2014-02-07 |
| 2011-12-31 | $22.55M 10-K · filed 2013-02-21 |
| 2010-12-31 | $35.76M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |